Corrigendum to "Biochemical, cellular and structural characterization of novel and selective ERK3 inhibitors" [Bioorg. Med. Chem. Lett. 30 (2020) 127551].

Grädler, Ulrich; Busch, Michael; Leuthner, Birgitta; Raba, Michael; Burgdorf, Lars; Lehmann, Martin; Linde, Nina; Esdar, Christina

Grädler, Ulrich; Busch, Michael; Leuthner, Birgitta; Raba, Michael; Burgdorf, Lars; Lehmann, Martin; Linde, Nina; Esdar, Christina.

Afiliación

Grädler U; Merck KGaA, Frankfurter Str. 250, D-64293 Darmstadt, Germany. Electronic address: ulrich.graedler@merckgroup.com.
Busch M; Merck KGaA, Frankfurter Str. 250, D-64293 Darmstadt, Germany.
Leuthner B; Merck KGaA, Frankfurter Str. 250, D-64293 Darmstadt, Germany.
Raba M; Crelux GmbH - a WuXi AppTec Company, Am Klopferspitz 19 a, D-82152 München, Germany.
Burgdorf L; Merck KGaA, Frankfurter Str. 250, D-64293 Darmstadt, Germany.
Lehmann M; Merck KGaA, Frankfurter Str. 250, D-64293 Darmstadt, Germany.
Linde N; Merck KGaA, Frankfurter Str. 250, D-64293 Darmstadt, Germany.
Esdar C; Merck KGaA, Frankfurter Str. 250, D-64293 Darmstadt, Germany.

Bioorg Med Chem Lett ; 49: 128262, 2021 Oct 01.

Article en En | MEDLINE | ID: mdl-34352662

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Bioorg Med Chem Lett Asunto de la revista: BIOQUIMICA / QUIMICA Año: 2021 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google